829 kr

Beställningsvara. Skickas inom 11-20 vardagar
Fri frakt för medlemmar vid köp för minst 249 kr.

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.Table of ContentsFront MatterProceedings of a WorkshopAppendix A: Statement of TaskAppendix B: Workshop Agenda

Produktinformation

  • Utgivningsdatum2020-02-27
  • Mått152 x 229 x undefined mm
  • FormatHäftad
  • SpråkEngelska
  • Antal sidor102
  • FörlagNational Academies Press
  • ISBN9780309498487

Mer från samma författare

Du kanske också är intresserad av